Syndax Pharmaceuticals Inc (SNDX)
Financing Cash Flow
$272.88M
TTM · Period ending: · USD
SNDX Financing Cash Flow
Latest reported$272.88Mperiod ending
Latest reported$272.88Mperiod ending
SNDX TTM Cash from Financing ($20.89M → $272.88M)
TTM financing cash flow
High-resolution chart · PNG
SNDX financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 272,883,000 | |
| 20,664,000 | |
| 13,676,000 | |
| 355,184,000 | |
| 352,004,000 | |
| 352,129,000 | |
| 353,367,000 | |
| 264,425,000 | |
| 263,178,000 | |
| 263,826,000 | |
| 264,132,000 | |
| 169,151,000 | |
| 153,775,000 | |
| 174,171,000 | |
| 172,254,000 | |
| 118,531,000 | |
| 133,761,000 | |
| 118,061,000 | |
| 118,464,000 | |
| 147,343,000 | |
| 147,405,000 | |
| 250,386,000 | |
| 304,424,000 | |
| 165,824,000 | |
| 164,137,000 | |
| 55,142,000 | |
| 28,570,000 | |
| 34,657,000 | |
| 44,039,000 | |
| 44,122,000 | |
| 15,729,000 | |
| 35,198,000 | |
| 26,740,000 | |
| 75,638,000 | |
| 75,722,000 | |
| 50,284,000 | |
| 50,990,000 | |
| 771,000 | |
| 54,202,000 | |
| 44,844,000 | |
| 103,194,000 | |
| 123,103,000 | |
| 77,267,000 | |
| 90,444,000 | |
| 39,895,000 | |
| 20,326,000 | |
| 12,410,000 | |
| 20,290,000 | |
| 17,254,000 | |
| 19,151,000 | |
| 20,889,000 | |
| 9,015,173 |